Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

The most recent version of this article was published on 1 April 2008

Thorax. Published Online First: 19 October 2007. doi:10.1136/thx.2007.081893
Copyright © 2007 BMJ Publishing Group Ltd & British Thoracic Society

This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
thx.2007.081893v1
63/4/301    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dransfield, M. T
Right arrow Articles by Gerald, L. B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dransfield, M. T
Right arrow Articles by Gerald, L. B
Topic Collections
Right arrowRelevant Articles

Papers

Beta-blocker use and the risk of death in hospitalized patients with acute exacerbations of COPD

Mark T Dransfield 1*, Steven M Rowe 2, James E Johnson 2, William C Bailey 2 and Lynn B Gerald 2

1 University of Alabama at Birmingham and the Birmingham VA Medical Center, United States
2 University of Alabama at Birmingham, United States

* To whom correspondence should be addressed. E-mail: mdransfield99{at}msn.com.

Accepted 30 September 2007


*   Abstract

Background: Cardiovascular disease is a major cause of death among COPD patients and predicts hospitalization for acute exacerbation, in-hospital death, and post-discharge mortality. Although beta-blockers improve cardiovascular outcomes, COPD patients often do not receive them due to concerns about possible adverse pulmonary effects. There are no published data about beta-blocker use among inpatients with COPD exacerbations. We aimed to identify factors associated with beta-blocker use in this setting and to determine whether their use is associated with decreased in-hospital mortality. Methods: We reviewed administrative data from the University of Alabama Hospital and identified patients admitted between October 1999 and September 2006 with acute exacerbation of COPD as primary diagnosis or as secondary diagnosis with a primary diagnosis of acute respiratory failure. Demographics, co-morbidities, and medication use were recorded and subjects receiving beta-blockers were compared to those who did not. Multivariate regression analysis was performed to determine predictors of in-hospital death after controlling for known covariates and the propensity to receive beta-blockers. Results: 825 patients met inclusion criteria. In-hospital mortality was 5.2%. Those receiving beta-blockers (n=142) were older and more frequently had cardiovascular disease than those who did not. In multivariate analysis adjusting for potential confounders including the propensity score, beta-blocker use was associated with reduced mortality (OR=0.39; 95% CI: 0.14-0.99). Age, length of stay, number of prior exacerbations, the presence of respiratory failure, congestive heart failure, cerebrovascular disease, or liver disease also predicted in-hospital mortality (p<0.05). Conclusions: Beta-blocker use among inpatients with exacerbations of COPD is well tolerated and may be associated with reduced mortality. The potential protective effect of beta-blockers in this population warrants further study.


Keywords: COPD, acute exacerbations, beta-blockers, epidemiology


Relevant Articles

Airwaves
Wisia Wedzicha
Thorax 2008 63: 295. [Extract] [Full Text] [PDF]

Use of β blockers in patients with COPD
David H Au
Thorax 2008 63: 296-298. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
M. Moss, D. Wilkes, and L. B. Ware
Clinical Year in Review II: Pulmonary Infections in the Immunocompetent Host, Issues in the Training of Fellows and Residents, Asthma, and Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, September 15, 2008; 5(7): 745 - 750.
[Full Text] [PDF]


Home page
ThoraxHome page
D. H Au
Use of {beta} blockers in patients with COPD
Thorax, April 1, 2008; 63(4): 296 - 298.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 BMJ Publishing Group Ltd & British Thoracic Society